Backend-as-a-Service
Backend-as-a-service (BaaS) is the cloud computing service model, which helps the middleware that ... Read More
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Biosimilars/follow-on-biologics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Human growth hormone 1.2.3 Erythropoietin 1.2.4 Monoclonal antibodies 1.2.5 Insulin 1.2.6 Interferon 1.2.7 Granulocyte-Colony Stimulating Factor 1.2.8 Others 1.3 Market by Application 1.3.1 Global Biosimilars/follow-on-biologics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Blood Disorders 1.3.3 Oncology Diseases 1.3.4 Chronic and Autoimmune Diseases 1.3.5 Growth Hormone Deficiencies 1.3.6 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Biosimilars/follow-on-biologics Market Perspective (2016-2027) 2.2 Biosimilars/follow-on-biologics Growth Trends by Regions 2.2.1 Biosimilars/follow-on-biologics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Biosimilars/follow-on-biologics Historic Market Share by Regions (2016-2021) 2.2.3 Biosimilars/follow-on-biologics Forecasted Market Size by Regions (2022-2027) 2.3 Biosimilars/follow-on-biologics Industry Dynamic 2.3.1 Biosimilars/follow-on-biologics Market Trends 2.3.2 Biosimilars/follow-on-biologics Market Drivers 2.3.3 Biosimilars/follow-on-biologics Market Challenges 2.3.4 Biosimilars/follow-on-biologics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Biosimilars/follow-on-biologics Players by Revenue 3.1.1 Global Top Biosimilars/follow-on-biologics Players by Revenue (2016-2021) 3.1.2 Global Biosimilars/follow-on-biologics Revenue Market Share by Players (2016-2021) 3.2 Global Biosimilars/follow-on-biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Biosimilars/follow-on-biologics Revenue 3.4 Global Biosimilars/follow-on-biologics Market Concentration Ratio 3.4.1 Global Biosimilars/follow-on-biologics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Biosimilars/follow-on-biologics Revenue in 2020 3.5 Biosimilars/follow-on-biologics Key Players Head office and Area Served 3.6 Key Players Biosimilars/follow-on-biologics Product Solution and Service 3.7 Date of Enter into Biosimilars/follow-on-biologics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Biosimilars/follow-on-biologics Breakdown Data by Type 4.1 Global Biosimilars/follow-on-biologics Historic Market Size by Type (2016-2021) 4.2 Global Biosimilars/follow-on-biologics Forecasted Market Size by Type (2022-2027) 5 Biosimilars/follow-on-biologics Breakdown Data by Application 5.1 Global Biosimilars/follow-on-biologics Historic Market Size by Application (2016-2021) 5.2 Global Biosimilars/follow-on-biologics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Biosimilars/follow-on-biologics Market Size (2016-2027) 6.2 North America Biosimilars/follow-on-biologics Market Size by Type 6.2.1 North America Biosimilars/follow-on-biologics Market Size by Type (2016-2021) 6.2.2 North America Biosimilars/follow-on-biologics Market Size by Type (2022-2027) 6.2.3 North America Biosimilars/follow-on-biologics Market Size by Type (2016-2027) 6.3 North America Biosimilars/follow-on-biologics Market Size by Application 6.3.1 North America Biosimilars/follow-on-biologics Market Size by Application (2016-2021) 6.3.2 North America Biosimilars/follow-on-biologics Market Size by Application (2022-2027) 6.3.3 North America Biosimilars/follow-on-biologics Market Size by Application (2016-2027) 6.4 North America Biosimilars/follow-on-biologics Market Size by Country 6.4.1 North America Biosimilars/follow-on-biologics Market Size by Country (2016-2021) 6.4.2 North America Biosimilars/follow-on-biologics Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Biosimilars/follow-on-biologics Market Size (2016-2027) 7.2 Europe Biosimilars/follow-on-biologics Market Size by Type 7.2.1 Europe Biosimilars/follow-on-biologics Market Size by Type (2016-2021) 7.2.2 Europe Biosimilars/follow-on-biologics Market Size by Type (2022-2027) 7.2.3 Europe Biosimilars/follow-on-biologics Market Size by Type (2016-2027) 7.3 Europe Biosimilars/follow-on-biologics Market Size by Application 7.3.1 Europe Biosimilars/follow-on-biologics Market Size by Application (2016-2021) 7.3.2 Europe Biosimilars/follow-on-biologics Market Size by Application (2022-2027) 7.3.3 Europe Biosimilars/follow-on-biologics Market Size by Application (2016-2027) 7.4 Europe Biosimilars/follow-on-biologics Market Size by Country 7.4.1 Europe Biosimilars/follow-on-biologics Market Size by Country (2016-2021) 7.4.2 Europe Biosimilars/follow-on-biologics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Biosimilars/follow-on-biologics Market Size (2016-2027) 8.2 Asia-Pacific Biosimilars/follow-on-biologics Market Size by Type 8.2.1 Asia-Pacific Biosimilars/follow-on-biologics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Biosimilars/follow-on-biologics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Biosimilars/follow-on-biologics Market Size by Type (2016-2027) 8.3 Asia-Pacific Biosimilars/follow-on-biologics Market Size by Application 8.3.1 Asia-Pacific Biosimilars/follow-on-biologics Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Biosimilars/follow-on-biologics Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Biosimilars/follow-on-biologics Market Size by Application (2016-2027) 8.4 Asia-Pacific Biosimilars/follow-on-biologics Market Size by Region 8.4.1 Asia-Pacific Biosimilars/follow-on-biologics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Biosimilars/follow-on-biologics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Biosimilars/follow-on-biologics Market Size (2016-2027) 9.2 Latin America Biosimilars/follow-on-biologics Market Size by Type 9.2.1 Latin America Biosimilars/follow-on-biologics Market Size by Type (2016-2021) 9.2.2 Latin America Biosimilars/follow-on-biologics Market Size by Type (2022-2027) 9.2.3 Latin America Biosimilars/follow-on-biologics Market Size by Type (2016-2027) 9.3 Latin America Biosimilars/follow-on-biologics Market Size by Application 9.3.1 Latin America Biosimilars/follow-on-biologics Market Size by Application (2016-2021) 9.3.2 Latin America Biosimilars/follow-on-biologics Market Size by Application (2022-2027) 9.3.3 Latin America Biosimilars/follow-on-biologics Market Size by Application (2016-2027) 9.4 Latin America Biosimilars/follow-on-biologics Market Size by Country 9.4.1 Latin America Biosimilars/follow-on-biologics Market Size by Country (2016-2021) 9.4.2 Latin America Biosimilars/follow-on-biologics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Biosimilars/follow-on-biologics Market Size (2016-2027) 10.2 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Type 10.2.1 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Type (2016-2027) 10.3 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Application 10.3.1 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Application (2016-2027) 10.4 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Country 10.4.1 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Novartis (Sandoz) 11.1.1 Novartis (Sandoz) Company Details 11.1.2 Novartis (Sandoz) Business Overview 11.1.3 Novartis (Sandoz) Biosimilars/follow-on-biologics Introduction 11.1.4 Novartis (Sandoz) Revenue in Biosimilars/follow-on-biologics Business (2016-2021) 11.1.5 Novartis (Sandoz) Recent Development 11.2 Synthon Pharmaceuticals 11.2.1 Synthon Pharmaceuticals Company Details 11.2.2 Synthon Pharmaceuticals Business Overview 11.2.3 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Introduction 11.2.4 Synthon Pharmaceuticals Revenue in Biosimilars/follow-on-biologics Business (2016-2021) 11.2.5 Synthon Pharmaceuticals Recent Development 11.3 Teva Pharmaceutical Industries 11.3.1 Teva Pharmaceutical Industries Company Details 11.3.2 Teva Pharmaceutical Industries Business Overview 11.3.3 Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Introduction 11.3.4 Teva Pharmaceutical Industries Revenue in Biosimilars/follow-on-biologics Business (2016-2021) 11.3.5 Teva Pharmaceutical Industries Recent Development 11.4 LG Life Sciences 11.4.1 LG Life Sciences Company Details 11.4.2 LG Life Sciences Business Overview 11.4.3 LG Life Sciences Biosimilars/follow-on-biologics Introduction 11.4.4 LG Life Sciences Revenue in Biosimilars/follow-on-biologics Business (2016-2021) 11.4.5 LG Life Sciences Recent Development 11.5 Celltrion Biocon 11.5.1 Celltrion Biocon Company Details 11.5.2 Celltrion Biocon Business Overview 11.5.3 Celltrion Biocon Biosimilars/follow-on-biologics Introduction 11.5.4 Celltrion Biocon Revenue in Biosimilars/follow-on-biologics Business (2016-2021) 11.5.5 Celltrion Biocon Recent Development 11.6 Hospira 11.6.1 Hospira Company Details 11.6.2 Hospira Business Overview 11.6.3 Hospira Biosimilars/follow-on-biologics Introduction 11.6.4 Hospira Revenue in Biosimilars/follow-on-biologics Business (2016-2021) 11.6.5 Hospira Recent Development 11.7 Merck Serono (Merck) 11.7.1 Merck Serono (Merck) Company Details 11.7.2 Merck Serono (Merck) Business Overview 11.7.3 Merck Serono (Merck) Biosimilars/follow-on-biologics Introduction 11.7.4 Merck Serono (Merck) Revenue in Biosimilars/follow-on-biologics Business (2016-2021) 11.7.5 Merck Serono (Merck) Recent Development 11.8 Biogen idec 11.8.1 Biogen idec Company Details 11.8.2 Biogen idec Business Overview 11.8.3 Biogen idec Biosimilars/follow-on-biologics Introduction 11.8.4 Biogen idec Revenue in Biosimilars/follow-on-biologics Business (2016-2021) 11.8.5 Biogen idec Recent Development 11.9 Genentech (Roche) 11.9.1 Genentech (Roche) Company Details 11.9.2 Genentech (Roche) Business Overview 11.9.3 Genentech (Roche) Biosimilars/follow-on-biologics Introduction 11.9.4 Genentech (Roche) Revenue in Biosimilars/follow-on-biologics Business (2016-2021) 11.9.5 Genentech (Roche) Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Biosimilars/follow-on-biologics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Human growth hormone Table 3. Key Players of Erythropoietin Table 4. Key Players of Monoclonal antibodies Table 5. Key Players of Insulin Table 6. Key Players of Interferon Table 7. Key Players of Granulocyte-Colony Stimulating Factor Table 8. Key Players of Others Table 9. Global Biosimilars/follow-on-biologics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 10. Global Biosimilars/follow-on-biologics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 11. Global Biosimilars/follow-on-biologics Market Size by Regions (2016-2021) & (US$ Million) Table 12. Global Biosimilars/follow-on-biologics Market Share by Regions (2016-2021) Table 13. Global Biosimilars/follow-on-biologics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 14. Global Biosimilars/follow-on-biologics Market Share by Regions (2022-2027) Table 15. Biosimilars/follow-on-biologics Market Trends Table 16. Biosimilars/follow-on-biologics Market Drivers Table 17. Biosimilars/follow-on-biologics Market Challenges Table 18. Biosimilars/follow-on-biologics Market Restraints Table 19. Global Biosimilars/follow-on-biologics Revenue by Players (2016-2021) & (US$ Million) Table 20. Global Biosimilars/follow-on-biologics Market Share by Players (2016-2021) Table 21. Global Top Biosimilars/follow-on-biologics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilars/follow-on-biologics as of 2020) Table 22. Ranking of Global Top Biosimilars/follow-on-biologics Companies by Revenue (US$ Million) in 2020 Table 23. Global 5 Largest Players Market Share by Biosimilars/follow-on-biologics Revenue (CR5 and HHI) & (2016-2021) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Biosimilars/follow-on-biologics Product Solution and Service Table 26. Date of Enter into Biosimilars/follow-on-biologics Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Biosimilars/follow-on-biologics Market Size by Type (2016-2021) (US$ Million) Table 29. Global Biosimilars/follow-on-biologics Revenue Market Share by Type (2016-2021) Table 30. Global Biosimilars/follow-on-biologics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 31. Global Biosimilars/follow-on-biologics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 32. Global Biosimilars/follow-on-biologics Market Size Share by Application (2016-2021) & (US$ Million) Table 33. Global Biosimilars/follow-on-biologics Revenue Market Share by Application (2016-2021) Table 34. Global Biosimilars/follow-on-biologics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 35. Global Biosimilars/follow-on-biologics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 36. North America Biosimilars/follow-on-biologics Market Size by Type (2016-2021) (US$ Million) Table 37. North America Biosimilars/follow-on-biologics Market Size by Type (2022-2027) & (US$ Million) Table 38. North America Biosimilars/follow-on-biologics Market Size by Application (2016-2021) (US$ Million) Table 39. North America Biosimilars/follow-on-biologics Market Size by Application (2022-2027) & (US$ Million) Table 40. North America Biosimilars/follow-on-biologics Market Size by Country (2016-2021) & (US$ Million) Table 41. North America Biosimilars/follow-on-biologics Market Size by Country (2022-2027) & (US$ Million) Table 42. Europe Biosimilars/follow-on-biologics Market Size by Type (2016-2021) (US$ Million) Table 43. Europe Biosimilars/follow-on-biologics Market Size by Type (2022-2027) & (US$ Million) Table 44. Europe Biosimilars/follow-on-biologics Market Size by Application (2016-2021) (US$ Million) Table 45. Europe Biosimilars/follow-on-biologics Market Size by Application (2022-2027) & (US$ Million) Table 46. Europe Biosimilars/follow-on-biologics Market Size by Country (2016-2021) & (US$ Million) Table 47. Europe Biosimilars/follow-on-biologics Market Size by Country (2022-2027) & (US$ Million) Table 48. Asia-Pacific Biosimilars/follow-on-biologics Market Size by Type (2016-2021) (US$ Million) Table 49. Asia-Pacific Biosimilars/follow-on-biologics Market Size by Type (2022-2027) & (US$ Million) Table 50. Asia-Pacific Biosimilars/follow-on-biologics Market Size by Application (2016-2021) (US$ Million) Table 51. Asia-Pacific Biosimilars/follow-on-biologics Market Size by Application (2022-2027) & (US$ Million) Table 52. Asia-Pacific Biosimilars/follow-on-biologics Market Size by Region (2016-2021) & (US$ Million) Table 53. Asia-Pacific Biosimilars/follow-on-biologics Market Size by Region (2022-2027) & (US$ Million) Table 54. Latin America Biosimilars/follow-on-biologics Market Size by Type (2016-2021) (US$ Million) Table 55. Latin America Biosimilars/follow-on-biologics Market Size by Type (2022-2027) & (US$ Million) Table 56. Latin America Biosimilars/follow-on-biologics Market Size by Application (2016-2021) (US$ Million) Table 57. Latin America Biosimilars/follow-on-biologics Market Size by Application (2022-2027) & (US$ Million) Table 58. Latin America Biosimilars/follow-on-biologics Market Size by Country (2016-2021) & (US$ Million) Table 59. Latin America Biosimilars/follow-on-biologics Market Size by Country (2022-2027) & (US$ Million) Table 60. Middle East & Africa Biosimilars/follow-on-biologics Market Size by Type (2016-2021) (US$ Million) Table 61. Middle East & Africa Biosimilars/follow-on-biologics Market Size by Type (2022-2027) & (US$ Million) Table 62. Middle East & Africa Biosimilars/follow-on-biologics Market Size by Application (2016-2021) (US$ Million) Table 63. Middle East & Africa Biosimilars/follow-on-biologics Market Size by Application (2022-2027) & (US$ Million) Table 64. Middle East & Africa Biosimilars/follow-on-biologics Market Size by Country (2016-2021) & (US$ Million) Table 65. Middle East & Africa Biosimilars/follow-on-biologics Market Size by Country (2022-2027) & (US$ Million) Table 66. Novartis (Sandoz) Company Details Table 67. Novartis (Sandoz) Business Overview Table 68. Novartis (Sandoz) Biosimilars/follow-on-biologics Product Table 69. Novartis (Sandoz) Revenue in Biosimilars/follow-on-biologics Business (2016-2021) & (US$ Million) Table 70. Novartis (Sandoz) Recent Development Table 71. Synthon Pharmaceuticals Company Details Table 72. Synthon Pharmaceuticals Business Overview Table 73. Synthon Pharmaceuticals Biosimilars/follow-on-biologics Product Table 74. Synthon Pharmaceuticals Revenue in Biosimilars/follow-on-biologics Business (2016-2021) & (US$ Million) Table 75. Synthon Pharmaceuticals Recent Development Table 76. Teva Pharmaceutical Industries Company Details Table 77. Teva Pharmaceutical Industries Business Overview Table 78. Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Product Table 79. Teva Pharmaceutical Industries Revenue in Biosimilars/follow-on-biologics Business (2016-2021) & (US$ Million) Table 80. Teva Pharmaceutical Industries Recent Development Table 81. LG Life Sciences Company Details Table 82. LG Life Sciences Business Overview Table 83. LG Life Sciences Biosimilars/follow-on-biologics Product Table 84. LG Life Sciences Revenue in Biosimilars/follow-on-biologics Business (2016-2021) & (US$ Million) Table 85. LG Life Sciences Recent Development Table 86. Celltrion Biocon Company Details Table 87. Celltrion Biocon Business Overview Table 88. Celltrion Biocon Biosimilars/follow-on-biologics Product Table 89. Celltrion Biocon Revenue in Biosimilars/follow-on-biologics Business (2016-2021) & (US$ Million) Table 90. Celltrion Biocon Recent Development Table 91. Hospira Company Details Table 92. Hospira Business Overview Table 93. Hospira Biosimilars/follow-on-biologics Product Table 94. Hospira Revenue in Biosimilars/follow-on-biologics Business (2016-2021) & (US$ Million) Table 95. Hospira Recent Development Table 96. Merck Serono (Merck) Company Details Table 97. Merck Serono (Merck) Business Overview Table 98. Merck Serono (Merck) Biosimilars/follow-on-biologics Product Table 99. Merck Serono (Merck) Revenue in Biosimilars/follow-on-biologics Business (2016-2021) & (US$ Million) Table 100. Merck Serono (Merck) Recent Development Table 101. Biogen idec Company Details Table 102. Biogen idec Business Overview Table 103. Biogen idec Revenue in Biosimilars/follow-on-biologics Business (2016-2021) & (US$ Million) Table 104. Biogen idec Recent Development Table 105. Genentech (Roche) Company Details Table 106. Genentech (Roche) Business Overview Table 107. Genentech (Roche) Biosimilars/follow-on-biologics Product Table 108. Genentech (Roche) Revenue in Biosimilars/follow-on-biologics Business (2016-2021) & (US$ Million) Table 109. Genentech (Roche) Recent Development Table 110. Research Programs/Design for This Report Table 111. Key Data Information from Secondary Sources Table 112. Key Data Information from Primary Sources List of Figures Figure 1. Global Biosimilars/follow-on-biologics Market Share by Type: 2020 VS 2027 Figure 2. Human growth hormone Features Figure 3. Erythropoietin Features Figure 4. Monoclonal antibodies Features Figure 5. Insulin Features Figure 6. Interferon Features Figure 7. Granulocyte-Colony Stimulating Factor Features Figure 8. Others Features Figure 9. Global Biosimilars/follow-on-biologics Market Share by Application: 2020 VS 2027 Figure 10. Blood Disorders Case Studies Figure 11. Oncology Diseases Case Studies Figure 12. Chronic and Autoimmune Diseases Case Studies Figure 13. Growth Hormone Deficiencies Case Studies Figure 14. Others Case Studies Figure 15. Biosimilars/follow-on-biologics Report Years Considered Figure 16. Global Biosimilars/follow-on-biologics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 17. Global Biosimilars/follow-on-biologics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 18. Global Biosimilars/follow-on-biologics Market Share by Regions: 2020 VS 2027 Figure 19. Global Biosimilars/follow-on-biologics Market Share by Regions (2022-2027) Figure 20. Global Biosimilars/follow-on-biologics Market Share by Players in 2020 Figure 21. Global Top Biosimilars/follow-on-biologics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilars/follow-on-biologics as of 2020 Figure 22. The Top 10 and 5 Players Market Share by Biosimilars/follow-on-biologics Revenue in 2020 Figure 23. Global Biosimilars/follow-on-biologics Revenue Market Share by Type (2016-2021) Figure 24. Global Biosimilars/follow-on-biologics Revenue Market Share by Type (2022-2027) Figure 25. North America Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. North America Biosimilars/follow-on-biologics Market Share by Type (2016-2027) Figure 27. North America Biosimilars/follow-on-biologics Market Share by Application (2016-2027) Figure 28. North America Biosimilars/follow-on-biologics Market Share by Country (2016-2027) Figure 29. United States Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Canada Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Europe Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Europe Biosimilars/follow-on-biologics Market Share by Type (2016-2027) Figure 33. Europe Biosimilars/follow-on-biologics Market Share by Application (2016-2027) Figure 34. Europe Biosimilars/follow-on-biologics Market Share by Country (2016-2027) Figure 35. Germany Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. France Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. U.K. Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Italy Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Russia Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Nordic Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Asia-Pacific Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Asia-Pacific Biosimilars/follow-on-biologics Market Share by Type (2016-2027) Figure 43. Asia-Pacific Biosimilars/follow-on-biologics Market Share by Application (2016-2027) Figure 44. Asia-Pacific Biosimilars/follow-on-biologics Market Share by Region (2016-2027) Figure 45. China Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Japan Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. South Korea Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Southeast Asia Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. India Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Australia Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Latin America Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Latin America Biosimilars/follow-on-biologics Market Share by Type (2016-2027) Figure 53. Latin America Biosimilars/follow-on-biologics Market Share by Application (2016-2027) Figure 54. Latin America Biosimilars/follow-on-biologics Market Share by Country (2016-2027) Figure 55. Mexico Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Brazil Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Middle East & Africa Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Middle East & Africa Biosimilars/follow-on-biologics Market Share by Type (2016-2027) Figure 59. Middle East & Africa Biosimilars/follow-on-biologics Market Share by Application (2016-2027) Figure 60. Middle East & Africa Biosimilars/follow-on-biologics Market Share by Country (2016-2027) Figure 61. Turkey Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. Saudi Arabia Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 63. UAE Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 64. Novartis (Sandoz) Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2016-2021) Figure 65. Synthon Pharmaceuticals Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2016-2021) Figure 66. Teva Pharmaceutical Industries Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2016-2021) Figure 67. LG Life Sciences Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2016-2021) Figure 68. Celltrion Biocon Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2016-2021) Figure 69. Hospira Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2016-2021) Figure 70. Merck Serono (Merck) Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2016-2021) Figure 71. Biogen idec Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2016-2021) Figure 72. Genentech (Roche) Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2016-2021) Figure 73. Bottom-up and Top-down Approaches for This Report Figure 74. Data Triangulation Figure 75. Key Executives Interviewed
Novartis (Sandoz) Synthon Pharmaceuticals Teva Pharmaceutical Industries LG Life Sciences Celltrion Biocon Hospira Merck Serono (Merck) Biogen idec Genentech (Roche)
Backend-as-a-service (BaaS) is the cloud computing service model, which helps the middleware that ... Read More
Ballistic targeting software is widely used by military services and professional hunters. This s ... Read More
Barcode software refers to the technology that enables users to design, create, and print barcode ... Read More
Bariatric surgeries are used for weight loss by decreasing the distending capacity of stomach to ... Read More